Prescribing inhalers offers physicians a chance to impact climate change — but switching to greener options comes with ...

Each patient using inhalers with propellants in 2023 produced 140kg of CO2 emissions over a year. Read more at ...

Aptar Digital Health's HeroTracker® Sense has been granted by the U.S Food and Drug Administration 510(k) clearance as a ...

The FDA accepted a new drug application for a single inhaler that contains beclomethasone dipropionate, formoterol fumarate ...

The FDA has accepted for review the NDA for Chiesi’s single inhaler triple therapy for the maintenance treatment of asthma in adults.

Asthma remains a significant health burden in the U.S., with more than 60% of adults continuing to experience frequent symptoms despite the ...

The FDA has accepted for review Chiesi’s New Drug Application (NDA) for their investigational maintenance treatment for ...

Wayflyer, the leading financing platform for consumer brands, today announced the launch of Hosted Capital, a new solution that enables service providers to commerce brands to seamlessly embed lending ...

Princeton Biopartners, a leading consultancy in Integrated Evidence Generation Planning and Medical Affairs strategy, today announced the launch of EVEXA®, a groundbreaking platform that ...

SingHealth hopes the study will raise awareness among asthma patients that managing their condition effectively is good for ...

For the first time, researchers have shown that tackling obstructive sleep apnea’s two root causes at once, using both oxygen ...